eprazinone has been researched along with Seizures in 1 studies
eprazinone : A member of the class of piperazines in which the two amino hydrogens of piperazine are replaced by 2-benzoylpropyl and 2-ethoxy-2-phenylethyl groups.
Seizures: Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent seizures are usually referred to as EPILEPSY or seizure disorder.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Merigot, P | 1 |
| Garnier, R | 1 |
| Efthymiou, ML | 1 |
1 other study available for eprazinone and Seizures
| Article | Year |
|---|---|
[Convulsions with 3 antitussive substituted derivatives of piperazine (zipeprol, eprazinone, eprozinol)].
Topics: Adult; Antitussive Agents; Child; Child, Preschool; Female; Humans; Infant; Male; Piperazines; Propi | 1985 |